Antibiotic use and the development of Crohn's disease

Card, T.; Logan, R. F. A.; Rodrigues, L. C.; Wheeler, J. G.
February 2004
Gut;Feb2004, Vol. 53 Issue 2, p246
Academic Journal
Background: Few environmental determinants of Crohn's disease are well established. Some observational data exist to implicate antibiotic use as a risk factor but these are derived from studies using questionnaires to assess reported antibiotic use that were susceptible to recall bias. We have therefore explored this relationship in prospectively gathered data. Methods: We selected incident cases of Crohn's disease from the General Practice Research Database with at least five years of data prior to diagnosis. Controls with five years of complete data were randomly selected. Data were extracted on smoking, drug prescriptions, age, sex, and a variety of symptoms and diagnoses that might be indicative of occult Crohn's disease. Logistic regression was used to investigate the relationship between antibiotic use and Crohn's disease. Results: A total of 587 Crohn's disease cases and 1460 controls were available for analysis. We found that antibiotic use 2-5 years pre-diagnosis occurred in 71 % of cases compared with 58% of controls (p<0.001), and the median number of courses was two in the cases and one in the controls (p<0.001). Adjusting for age, sex, smoking, and use of other drugs, antibiotic use had an odds ratio of 1 .32 (1 .05- 1 .65). We were unable to show specificity to any subgroup of antibacterials. Associations similar to that with antibiotics were also found with oral contraceptive, cardiovascular, and neurological drugs. Conclusions: We found a statistically significant association between Crohn's disease and prior antibiotic use. This cannot be explained by recall bias, but due to lack of specificity it is unclear whether it is causal.


Related Articles

  • Antibiotic use and the development of Crohn's disease: methodological issues. Schneider, V.; Suissa, S. // Gut;Oct2004, Vol. 53 Issue 10, p1544 

    This article reports that the use of antibiotics could increase the risk of Crohn's disease, particularly those prescribed 2-5 years prior to the diagnosis. As the use of drugs acting on the central nervous system and of other prescription drugs such as oral contraceptives was also associated...

  • Progestin-only emergency contraception pill now available. Hayes, Gloria; Lucas, Beverly // Patient Care;9/30/1999, Vol. 33 Issue 15, p12 

    Reports on the approval granted by the United States Food and Drug Administration to Plan B, the first progestin-only pill (POP) regimen for postcoital contraception. Superiority of POP over the traditional Yuzpe method; Dosage required by the regimen; Side effects.

  • Is There an Increased Risk of Stroke Associated with Oral Contraceptives? Zeitoun, K.; Carr, B.R. // Drug Safety;Jun1999, Vol. 20 Issue 6, p467 

    In the last few years several studies were published about the relationship between oral contraceptive use, estrogen dose, different types of progestogens, cigarette smoking and the risk of stroke. There is a persistent association between the use of oral contraceptives containing more than...

  • Progestogens with Antiandrogenic Properties. Raudrant, D.; Rabe, T. // Drugs;2003, Vol. 63 Issue 5, p463 

    Chlormadinone acetate, cyproterone acetate and dienogest are potent, orally active progestogens, which have antiandrogenic instead of partial androgenic activity. They act mainly by blocking androgen receptors in target organs, but also reduce the activity of skin 5α-reductase, the enzyme...

  • Progestin-Only OCs for Breastfeeding Women.  // Population Reports;Spring2000, Vol. 28 Issue 1, p5 

    Focuses on progestin-only oral contraceptives as an ideal birth control pill for women who are breastfeeding their babies.

  • Serum Gonadotropin and Sperm Suppression Link in T-Progestin Contraceptive.  // Fertility Weekly;3/22/2004, p7 

    Presents the findings of a research appearing in "The Journal of Clinical Endocrinology & Metabolism" regarding the suppression of sperm concentration through gonadotropin dependency by T-progestin contraceptives.

  • Colonic Crohn's disease and use of oral contraception. Rhodes, J.M.; Cockel, R.; Allan, R.N.; Hawker, P.C.; Dawson, J.; Elias, E. // British Medical Journal (Clinical Research Edition);2/25/1984, Vol. 288 Issue 6417, p595 

    Examines the use of oral contraceptives before the onset of disease in patients with isolated colonic Crohn's disease in Birmingham, England. Remission of the disease in stopping the intake of oral contraceptives; Need to recommend alternative forms of contraception in women with ischemic...

  • Progestin-only emergency contraceptive approved. Maudlin, Robert K. // Modern Medicine;Oct99, Vol. 67 Issue 10, p55 

    Announces the Women's Capital Corporation's approval of Plan B, a progestin-only emergency contraceptive which prevents pregnancy after contraceptive accident or unprotected sex. Drug indication; Effectiveness; Side effects.

  • Oral Contraceptives and Venous Thromboembolism: Which Are the Safest Preparations Available? Girolami, A.; Spiezia, L.; Rossi, F.; Zanon, E. // Clinical & Applied Thrombosis/Hemostasis;Apr2002, Vol. 8 Issue 2, p157 

    Oral contraceptive therapy is associated with a fourfold increased risk of venous thromboembolism as compared with age-matched non-users. The composition of oral contraceptives has varied considerably during the past two to three decades. The estrogen content (ethinylestradiol) has decreased and...


Read the Article


Sign out of this library

Other Topics